IGS Launches New Large-Scale COVID-19 Testing

Learn More

GCID IGS was awarded $17.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to fund the Genome Center for Infectious Diseases (GCID) for another five years.
Maryland Genomics Maryland Genomics offers high-throughput, cost-effective sequencing and bioinformatics analysis services at the University of Maryland Institute for Genome Sciences.
ARGOS The FDA ARGOS database generates quality-controlled microbial reference genomes for diagnostic use, which enable ID-NGS developers to perform in silico validation of their workflows. FDA and IGS solicit submissions of microbial samples for complimentary sequencing and analysis and inclusion in the ARGOS database.
New Classification of Names of Genetic Diseases Lynn M. Schriml, PhD, the principal investigator on a recently funded, $3.4 million five-year U41 Genomic Resource grant that was awarded by the National Human Genome Research Institute (NHGRI), entitled "the Human Disease Ontology" project.
NeMO New NIH Brain Initiative Cell Census Network Launched. For the BRAIN Initiative, IGS researchers will develop a data repository (NeMO) focused on the storage and dissemination of 'omic' data from the BRAIN initiative and related brain research projects.
Using 3D Printing to Create Environmental DNA Research Tools The analysis of environmental DNA (eDNA) using next-generation sequencing is a powerful technique to identify and characterize organisms that leave traces of their DNA when they shed cells, hair, or when they decay.

Current News

September 2020

UMSOM Researchers Receive $7 Million Grant to Establish Data Ctr for HIV and Substance Abuse Disorders

Researchers at UMSOM have received a nearly $7 million grant to be disbursed over five years from the National Institute on Drug Abuse (NIDA)...

July 2020

UM School of Medicine Researchers Receive Federal Funding to Rapidly Test New Treatments for COVID-19

Researchers at UM SOM will be partnering on an agreement funded by the federal government’s Defense Advanced Research Projects Agency (DARPA) to rapidly test hundreds of drugs, approved and marketed for other conditions, to see whether any can be repurposed to prevent or treat COVID-19......

May 2020

Robots to Speed Up Maryland Testing

As the coronavirus....

Recent Publications